AG NPP709 is now available on the market; nonetheless, no study has investigated the outcome of AG NPP709 in sufferers with COPD. As a result, the purpose of the study was To judge the efficacy of AG NPP709 in patients with Serious bronchitis variety COPD.Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis componen